Alzheimer’s Disease – Pipeline Review, H2 2016, provides an overview of the Alzheimer’s Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Alzheimer’s Disease , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
Browse more detail information about Alzheimer’s Disease at:
The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Alzheimer’s Disease and features dormant and discontinued projects.
Key players in Alzheimer’s Disease – Pipeline Review, H2 2016:
- Axxam SpA
- Beactica AB
- Berg LLC
- BioArctic Neuroscience AB
- Bioasis Technologies Inc.
- Biogen Inc
- Biomar Microbial Technologies
- Bionature E.A. Ltd.
- Boehringer Ingelheim GmbH
- Bristol-Myers Squibb Company
- Cardax Pharmaceuticals, Inc.
- Carna Biosciences, Inc.
- Celon Pharma Sp. z o.o.
- CHA Bio & Diostech Co., Ltd.
- Chase Pharmaceuticals Corporation
- Clera Inc.
- Cognition Therapeutics, Inc.
- Cognosci, Inc.
Get a PDF Sample of Alzheimer’s Disease Market Research Report at: http://www.marketreportsworld.com/enquiry/request-sample/10269360
List of Figures of Alzheimer’s Disease Therapeutics Market Included:
- Introduction 12
- Alzheimer’s Disease Overview 13
- Therapeutics Development 14
- Alzheimer’s Disease – Therapeutics under Development by Companies 16
- Alzheimer’s Disease – Therapeutics under Investigation by Universities/Institutes 37
- Alzheimer’s Disease – Pipeline Products Glance 44
- Alzheimer’s Disease – Products under Development by Companies 48
- Alzheimer’s Disease – Products under Investigation by Universities/Institutes 78
- Alzheimer’s Disease – Companies Involved in Therapeutics Development 88
- Alzheimer’s Disease – Therapeutics Assessment 316
- Drug Profiles 372
- Alzheimer’s Disease – Dormant Projects 1152
- Alzheimer’s Disease – Discontinued Products 1199
- Alzheimer’s Disease – Product Development Milestones 1209
- Appendix 1221
Get Discount on Alzheimer’s Disease Market Research Report at: http://www.marketreportsworld.com/enquiry/request-discount/10269360
Scope of Alzheimer’s Disease Pipeline Review Report-
– The report provides a snapshot of the global therapeutic landscape of Alzheimer’s Disease
– The report reviews pipeline therapeutics for Alzheimer’s Disease by companies and universities/research institutes based on information derived from company and industry-specific sources
– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
About Market Reports World:
Market Reports World is the credible source for gaining the market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed towards optimizing your business. The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segments.
Mr. Ameya Pingaley
Market Reports World
+1-408 520 9750
Email – email@example.com
Get more market research related news @ www.marketresearch.news